Company Profile

Furtim Therapeutics LLC
Profile last edited on: 9/20/2018      CAGE: 7MZ43      UEI: CQ3MV2N991K4

Business Identifier: Bio-conjugation for therapeutic applications
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4000 Mason Road Suite 304
Seattle, WA 98105
   (425) 273-1035
Location: Single
Congr. District: 07
County: King

Public Profile

Furtim Therapeutics LLC specializes in bio-conjugation for therapeutic applications. The firm's PI has expertise in bio-conjugate purification, Conjugate biochemical characterization. Acute Lymphoblastic Leukemia, Animal sera analysis, immunogenicity, pharmacokinetics, pharmacodynamics, animal protocol development.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  George Sellhorn -- Principal

  Wenchen Li -- Research Scientist

Company News

There are no news available.